tetano
Editor, Senior Moderator
J Infect Dev Ctries
. 2022 Nov 29;16(11):1703-1705.
doi: 10.3855/jidc.16998.
Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam
Pham Dang Hai[SUP] 1 [/SUP], Le Lan Phuong[SUP] 2 [/SUP], Nguyen Hong Tot[SUP] 2 [/SUP], Nguyen Le Phuong Anh[SUP] 3 [/SUP], Nguyen Dinh Tung[SUP] 4 [/SUP], Nguyen Hong Quan[SUP] 5 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020 and since then it has spread to almost every country around the world. Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have been reported. We present two cases of Guillain-Barré Syndrome (GBS) after receiving the ChAdOx1 nCoV-19 vaccine (Oxford- AstraZeneca). Both cases were admitted to the 108 Military Central Hospital, Vietnam, and received plasmapheresis therapy with satisfactory recovery after treatment.
Keywords: COVID-19; GBS; Guillain-Barré syndrome; plasmapheresis; vaccination.
. 2022 Nov 29;16(11):1703-1705.
doi: 10.3855/jidc.16998.
Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam
Pham Dang Hai[SUP] 1 [/SUP], Le Lan Phuong[SUP] 2 [/SUP], Nguyen Hong Tot[SUP] 2 [/SUP], Nguyen Le Phuong Anh[SUP] 3 [/SUP], Nguyen Dinh Tung[SUP] 4 [/SUP], Nguyen Hong Quan[SUP] 5 [/SUP]
Affiliations
- PMID: 36449641
- DOI: 10.3855/jidc.16998
Abstract
Coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization in March 2020 and since then it has spread to almost every country around the world. Vaccines against COVID-19 are considered an essential measure to curb this pandemic. However, side effects, including local and systemic reactions, after administering the COVID-19 vaccine have been defined, and some side effects have been reported. We present two cases of Guillain-Barré Syndrome (GBS) after receiving the ChAdOx1 nCoV-19 vaccine (Oxford- AstraZeneca). Both cases were admitted to the 108 Military Central Hospital, Vietnam, and received plasmapheresis therapy with satisfactory recovery after treatment.
Keywords: COVID-19; GBS; Guillain-Barré syndrome; plasmapheresis; vaccination.